Sunday 7 December 2014

Nivolumab Scores in Tough-to-Treat Hodgkin's Lymphoma (CME/CE)

(MedPage Today) -- Investigational drug produces long-lasting response rates in heavily pre-treated Hodgkin's lymphoma. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment